サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413109

顧みられない熱帯病診断市場：サービス、疾患、診断方法、最終用途別-2024-2030年の世界予測

Neglected Tropical Diseases Diagnosis Market by Service (Centralized Service, POC Service), Disease (African Trypanosomiasis, Buruli Ulcer, Chagas Disease), Diagnostic Method, End-Use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
顧みられない熱帯病診断市場：サービス、疾患、診断方法、最終用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顧みられない熱帯病診断市場規模は2023年に66億9,000万米ドルと推計され、2024年には70億4,000万米ドルに達し、CAGR 5.80%で2030年には99億3,000万米ドルに達すると予測されます。

顧みられない熱帯病診断の世界市場

主な市場の統計
基準年[2023］ 66億9,000万米ドル
予測年[2024］ 70億4,000万米ドル
予測年 [2030] 99億3,000万米ドル
CAGR（%） 5.8%
顧みられない熱帯病診断 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは顧みられない熱帯病診断市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、顧みられない熱帯病診断市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-顧みられない熱帯病診断市場の市場規模および予測は？

2-顧みられない熱帯病診断市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-顧みられない熱帯病診断市場における技術動向と規制の枠組みは？

4-顧みられない熱帯病診断市場における主要ベンダーの市場シェアは？

5-顧みられない熱帯病診断市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 顧みられない熱帯病に取り組むプログラムの数が増加
      • 熱帯および亜熱帯諸国における顧みられない熱帯病の蔓延
      • 病気の早期発見に対する需要の高まり
    • 抑制要因
      • 発展途上国における顧みられない熱帯病の治療意識の欠如
    • 機会
      • 先進的な顧みられない熱帯病診断装置の開発が進む
      • 革新的な顧みられない熱帯病の診断を開発するための研究開発の増加
    • 課題
      • 診断のための標準化ツールの欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 顧みられない熱帯病診断市場：サービス別

  • 一元化されたサービス
  • POCサービス

第7章 顧みられない熱帯病診断市場：疾患別

  • アフリカトリパノソーマ症
  • ブルーリ潰瘍
  • シャーガス病
  • チクングニア熱
  • デング熱
  • ドラクンキュリア症
  • エキノコックス症
  • 食中毒吸虫症
  • リーシュマニア症
  • ハンセン病
  • リンパ系フィラリア症
  • オンコセルカ症
  • 狂犬病
  • 疥癬
  • 住血吸虫症
  • ヘビに噛まれたときの毒
  • 土壌伝染性蠕虫感染症
  • 条虫症/嚢胞虫症
  • ヨーズ

第8章 顧みられない熱帯病診断市場診断方法別

  • 従来の方法
  • 分子/現代的手法

第9章 顧みられない熱帯病診断市場：最終用途別

  • 臨床検査室
  • 在宅ヘルスケア
  • 病院・診療所

第10章 南北アメリカの顧みられない熱帯病診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の顧みられない熱帯病診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの顧みられない熱帯病診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Coris BioConcept SPRL
    • DiaSys Diagnostic Systems GmbH
    • F. Hoffmann-La Roche Ltd
    • Genome Diagnostics Pvt. Ltd.
    • InBios International, Inc.
    • Omega Diagnostics Group PLC
    • Ortho Clinical Diagnostics
    • Oscar Medicare Pvt. Ltd.
    • Premier Medical Corporation Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix LLC
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET DYNAMICS
  • FIGURE 7. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 10. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 12. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 9. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 204. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 205. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET LICENSE & PRICING
目次
Product Code: MRR-742BD5181ED7

[195 Pages Report] The Neglected Tropical Diseases Diagnosis Market size was estimated at USD 6.69 billion in 2023 and expected to reach USD 7.04 billion in 2024, at a CAGR 5.80% to reach USD 9.93 billion by 2030.

Global Neglected Tropical Diseases Diagnosis Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.69 billion
Estimated Year [2024] USD 7.04 billion
Forecast Year [2030] USD 9.93 billion
CAGR (%) 5.8%
Neglected Tropical Diseases Diagnosis Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neglected Tropical Diseases Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neglected Tropical Diseases Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Diseases Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Coris BioConcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt. Ltd., InBios International, Inc., Omega Diagnostics Group PLC, Ortho Clinical Diagnostics, Oscar Medicare Pvt. Ltd., Premier Medical Corporation Ltd., Siemens AG, Thermo Fisher Scientific Inc., and ZeptoMetrix LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Diseases Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Service
    • Centralized Service
    • POC Service
  • Disease
    • African Trypanosomiasis
    • Buruli Ulcer
    • Chagas Disease
    • Chikungunya
    • Dengue
    • Dracunculiasis
    • Echinococcosis
    • Foodborne Trematodiases
    • Leishmaniasis
    • Leprosy
    • Lymphatic Filariasis
    • Onchocerciasis
    • Rabies
    • Scabies
    • Schistosomiasis
    • Snakebite Envenoming
    • Soil-transmitted Helminth Infections
    • Taeniasis/Cysticercosis
    • Yaws
  • Diagnostic Method
    • Conventional Method
    • Molecular/Modern Method
  • End-Use
    • Clinical Labs
    • Home Healthcare
    • Hospitals /Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neglected Tropical Diseases Diagnosis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neglected Tropical Diseases Diagnosis Market?

3. What are the technology trends and regulatory frameworks in the Neglected Tropical Diseases Diagnosis Market?

4. What is the market share of the leading vendors in the Neglected Tropical Diseases Diagnosis Market?

5. Which modes and strategic moves are suitable for entering the Neglected Tropical Diseases Diagnosis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neglected Tropical Diseases Diagnosis Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in number of programs to tackle neglected tropical diseases
      • 5.1.1.2. Rising prevalence of neglected tropical diseases in tropical and subtropical countries
      • 5.1.1.3. Growing demand for early disease identification
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of neglected tropical diseases treatment awareness in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of advanced neglected tropical disease diagnosis devices
      • 5.1.3.2. Rising R&D to develop innovative neglected tropical disease diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Neglected Tropical Diseases Diagnosis Market, by Service

  • 6.1. Introduction
  • 6.2. Centralized Service
  • 6.3. POC Service

7. Neglected Tropical Diseases Diagnosis Market, by Disease

  • 7.1. Introduction
  • 7.2. African Trypanosomiasis
  • 7.3. Buruli Ulcer
  • 7.4. Chagas Disease
  • 7.5. Chikungunya
  • 7.6. Dengue
  • 7.7. Dracunculiasis
  • 7.8. Echinococcosis
  • 7.9. Foodborne Trematodiases
  • 7.10. Leishmaniasis
  • 7.11. Leprosy
  • 7.12. Lymphatic Filariasis
  • 7.13. Onchocerciasis
  • 7.14. Rabies
  • 7.15. Scabies
  • 7.16. Schistosomiasis
  • 7.17. Snakebite Envenoming
  • 7.18. Soil-transmitted Helminth Infections
  • 7.19. Taeniasis/Cysticercosis
  • 7.20. Yaws

8. Neglected Tropical Diseases Diagnosis Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional Method
  • 8.3. Molecular/Modern Method

9. Neglected Tropical Diseases Diagnosis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Labs
  • 9.3. Home Healthcare
  • 9.4. Hospitals /Clinics

10. Americas Neglected Tropical Diseases Diagnosis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neglected Tropical Diseases Diagnosis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neglected Tropical Diseases Diagnosis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Bio-Rad Laboratories, Inc.
    • 14.1.3. Coris BioConcept SPRL
    • 14.1.4. DiaSys Diagnostic Systems GmbH
    • 14.1.5. F. Hoffmann-La Roche Ltd
    • 14.1.6. Genome Diagnostics Pvt. Ltd.
    • 14.1.7. InBios International, Inc.
    • 14.1.8. Omega Diagnostics Group PLC
    • 14.1.9. Ortho Clinical Diagnostics
    • 14.1.10. Oscar Medicare Pvt. Ltd.
    • 14.1.11. Premier Medical Corporation Ltd.
    • 14.1.12. Siemens AG
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. ZeptoMetrix LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing